category

Biocon announces conclusion of USFDA preapproval inspection of its insulin manufacturing facility at Bangalore

 

Biocon announced that USFDA concluded a pre-approval inspection of Biocon's insulin drug substance manufacturing facility triggered by a New Drug Application submitted by the c...read more





Daily News

VIEW ALL